MEDIUM confidence: 100% data completeness, but the composite (50) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15.3B— | $20.3B+32.7% | $23.0B+13.4% | $22.9B-0.3% | $22.2B-3.3% |
| EPS (dil.) | $1.63— | $1.73+6.1% | $2.92+68.8% | $2.83-3.1% | $1.50-47.0% |
| Free Cash Flow | $1.1B— | $1.2B+10.7% | $2.1B+68.9% | $2.4B+16.5% | $1.7B-31.0% |
| Gross Margin | 13.2% | 16.0%+2.8pp | 18.9%+3.0pp | 18.7%-0.2pp | 15.7%-3.0pp |
| Operating Margin | 11.8% | 13.3%+1.6pp | 17.7%+4.4pp | 16.7%-1.1pp | 10.2%-6.5pp |
| Net Margin | 9.5% | 7.7%-1.8pp | 11.5%+3.7pp | 10.9%-0.6pp | 5.8%-5.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 5.0%/yr (revenue basis).
Base free cash flow $2.1B (avg FY2023–FY2025; latest year $1.7B) · equity value $29.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $45 (last qtr, 6 analysts) → $46 (last mo, 5) (+1.3%).
Buy-rated share 72% → 76% over ~3 months (+3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.58 | $0.60 | +2.6% |
| Jul 2026 | $0.54 | $0.55 | +2.2% |
| Apr 2026 | $0.50 | $0.55 | +10.3% |
| Jan 2026 | $0.55 | $0.69 | +25.2% |
| Oct 2025 | $0.50 | $0.58 | +16.3% |
| Jul 2025 | $0.55 | $0.55 | -0.4% |
| Apr 2025 | $0.60 | $0.60 | -0.3% |
| Jan 2025 | $0.73 | $0.70 | -4.1% |
Net insider -$17.6M over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 50 indicates a neutral outlook for Halliburton, with the long-term and short-term scores closely aligned. The stock scores high on value, trading at a P/E of 15.1 and P/B of 2.7, which supports its score, while its growth category is a drag due to negative revenue and EPS growth. The stock exhibits strong momentum, with a 12-month return of 31.6%, but its profitability metrics, such as ROE of 18.5%, are somewhat muted, contributing to the overall neutral score.